Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.
The item "Payables-Turnover" stands at 2.91 as of 06/30/2025, the highest value since 09/30/2023.
As of the end of Sumitomo Dainippon Pharma Co Ltd's first quarter, the item "Payables Turnover" stands at 2.91. This represents an increase of 12.70 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.27 percent compared to the value the year prior.
The 1 year change in percent is 16.27.
The 3 year change in percent is -17.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Payables Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Payables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Payables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Payables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Payables Turnover | 280,205,508,085.11 |